Givaudan SA (GIN1) - Net Assets

Latest as of December 2025: €4.57 Billion EUR ≈ $5.34 Billion USD

Based on the latest financial reports, Givaudan SA (GIN1) has net assets worth €4.57 Billion EUR (≈ $5.34 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€11.86 Billion ≈ $13.87 Billion USD) and total liabilities (€7.30 Billion ≈ $8.53 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Givaudan SA to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets €4.57 Billion
% of Total Assets 38.5%
Annual Growth Rate 3.7%
5-Year Change 15.91%
10-Year Change N/A
Growth Volatility 6.79

Givaudan SA - Net Assets Trend (2016–2025)

This chart illustrates how Givaudan SA's net assets have evolved over time, based on quarterly financial data. See Givaudan SA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Givaudan SA (2016–2025)

The table below shows the annual net assets of Givaudan SA from 2016 to 2025. For live valuation and market cap data, see Givaudan SA market capitalisation.

Year Net Assets Change
2025-12-31 €4.57 Billion
≈ $5.34 Billion
-0.22%
2024-12-31 €4.58 Billion
≈ $5.35 Billion
+14.51%
2023-12-31 €4.00 Billion
≈ $4.67 Billion
-5.64%
2022-12-31 €4.24 Billion
≈ $4.95 Billion
+7.51%
2021-12-31 €3.94 Billion
≈ $4.61 Billion
+12.34%
2020-12-31 €3.51 Billion
≈ $4.10 Billion
-4.13%
2019-12-31 €3.66 Billion
≈ $4.28 Billion
-1.72%
2018-12-31 €3.72 Billion
≈ $4.35 Billion
+5.23%
2017-12-31 €3.54 Billion
≈ $4.14 Billion
+7.44%
2016-12-31 €3.29 Billion
≈ $3.85 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to Givaudan SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 35.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings €7.41 Billion 163.39%
Total Equity €4.54 Billion 100.00%

Givaudan SA Competitors by Market Cap

The table below lists competitors of Givaudan SA ranked by their market capitalization.

Company Market Cap
Atlas Copco AB Series B
ST:ATCO-B
$27.24 Billion
Otis Worldwide Corp
NYSE:OTIS
$27.25 Billion
Experian plc
F:J2B
$27.25 Billion
ZIJIN MIN.H UNSP.ADR/20
F:FJZB
$27.31 Billion
CenterPoint Energy Inc
NYSE:CNP
$27.17 Billion
Edison International
NYSE:EIX
$27.16 Billion
Hershey Co
NYSE:HSY
$27.16 Billion
Veeva Systems Inc Class A
NYSE:VEEV
$27.15 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Givaudan SA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,578,000,000 to 4,537,000,000, a change of -41,000,000 (-0.9%).
  • Net income of 1,071,000,000 contributed positively to equity growth.
  • Dividend payments of 645,000,000 reduced retained earnings.
  • Other factors decreased equity by 467,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €1.07 Billion +23.61%
Dividends Paid €645.00 Million -14.22%
Other Changes €-467.00 Million -10.29%
Total Change €- -0.90%

Book Value vs Market Value Analysis

This analysis compares Givaudan SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.12x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €384.17 €61.00 x
2018-12-31 €402.44 €61.00 x
2019-12-31 €394.96 €61.00 x
2020-12-31 €378.16 €61.00 x
2021-12-31 €426.06 €61.00 x
2022-12-31 €458.66 €61.00 x
2023-12-31 €432.74 €61.00 x
2024-12-31 €496.19 €61.00 x
2025-12-31 €491.59 €61.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Givaudan SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 23.61%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 14.33%
  • • Asset Turnover: 0.63x
  • • Equity Multiplier: 2.61x
  • Recent ROE (23.61%) is above the historical average (20.93%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 19.56% 13.81% 0.72x 1.98x €314.70 Million
2017 20.35% 14.25% 0.69x 2.07x €366.20 Million
2018 17.87% 12.00% 0.60x 2.50x €292.00 Million
2019 19.29% 11.32% 0.60x 2.86x €338.00 Million
2020 21.29% 11.75% 0.59x 3.05x €394.00 Million
2021 20.90% 12.28% 0.59x 2.91x €428.10 Million
2022 20.23% 12.03% 0.62x 2.72x €432.80 Million
2023 22.36% 12.91% 0.62x 2.79x €493.70 Million
2024 23.81% 14.71% 0.61x 2.64x €632.20 Million
2025 23.61% 14.33% 0.63x 2.61x €617.30 Million

Industry Comparison

This section compares Givaudan SA's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $785,166,340
  • Average return on equity (ROE) among peers: -453.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Givaudan SA (GIN1) €4.57 Billion 19.56% 1.60x $27.23 Billion
LIFELINE SPAC I OYJ A EO1 (0CD) $108.00 Million -8.98% 0.09x $261.36 Million
GRAPHENE MANUFACT.GROUP (0GF) $8.69 Million -107.23% 0.84x $185.36 Million
Orion Engineered Carbons SA (0OE) $474.90 Million 9.31% 2.91x $327.05 Million
COVESTRO AG SP.ADR 1/2 (1CO1) $7.02 Billion -9.18% 0.92x $11.11 Billion
H&R GmbH & Co. KGaA (2HRA) $84.33 Million 8.91% 2.91x $183.88 Million
LOOP INDUSTRIES DL-001 (3L9) $367.00K -4102.72% 49.62x $58.01 Million
Dotz Nano Ltd (57N) $-43.33 Million 0.00% 0.00x $4.51 Million
TIDEWATER RENEWABLES LTD (7GZ) $157.77 Million -226.85% 1.58x $233.52 Million
DIRECTA PLUS PLC LS-0025 (88K) $6.58 Million -58.58% 0.91x $2.35 Million
TEKNA HOLDING ASA NK 2 (8VB) $38.35 Million -37.60% 0.99x $67.10 Million

About Givaudan SA

F:GIN1 Germany Specialty Chemicals
Market Cap
$32.91 Billion
€28.15 Billion EUR
Market Cap Rank
#973 Global
#219 in Germany
Share Price
€61.00
Change (1 day)
-0.81%
52-Week Range
€56.50 - €88.00
All Time High
€98.50
About

Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & … Read more